Pathology
Nano-LCMS Differentiates Liver Diseases
Non-alcoholic steatohepatitis (NASH) is among the leading causes of liver disease worldwide. It is increasingly recognized that the phenotype of NASH may involve a number of different pathways, of which each could become important therapeutic targets. More...24 Sep 2018
Biomarker Tests Benefit Certain Cancer Patients
The benefit of biomarker tests has been reinvestigated to support the decision for or against adjuvant systemic chemotherapy in certain breast cancer patients, that is, women with primary hormone receptor-positive, HER2/neu-negative breast cancer and 0 to 3 affected lymph nodes. More...17 Sep 2018
Prognostic Biomarkers Identified for Aggressive Breast Cancer
The rarest, but also the most aggressive and hard to treat, form of breast cancer, is known as triple negative. For this type of cancer, oncologists have so far been unable to identify markers that can classify patients by prognosis or probability of responding to different treatments. More...11 Sep 2018
Colorectal Carcinoma Tumor Budding Automatically Evaluated
Tumor budding, meaning a detachment of tumor cells at the invasion front of colorectal carcinoma (CRC) into single cells or clusters has been shown to correlate to an inferior clinical outcome by several independent studies. More...10 Sep 2018
New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
HPV Test
Allplex HPV28 Detection
Electrolyte Analyzer
BKE-B
In Other News
Genotyping Assay Integrated into Glioma Treatment
Blood-Based Test Predicts Benefits of Lung Cancer Treatment
Genetic Mutation Identified in Childhood Brain Disorder
Genetic Testing for Hypercholesterolemia Improves Diagnosis
Urine Test Accurately Detects Bladder Cancer Recurrence
Cancer Risk Assessed by Circulating Protein Biomarker Panel
Infections Defined in Urothelial Bladder Tumors
Susceptible Genes Identified for Childhood Kidney Disease
Genetic Alterations Correlated to Aggressive Prostate Cancer
Melanoma Biomarkers Predict Checkpoint Blocker Response
New Target Protein for Colon Cancer Identified
Biomarker Detects Active Melanoma and Predicts Survival
Cancer Genetics Highlight Mutations Linked to Drug Response
Integrated Analyses Offer Molecular Insights to Tumor Subtypes
Obesity Affects Prostate Cancer Test Results
Inflammation Marker Tied to Dementia Increases with Age
Circulating Tumor Cell-Based AR-V7 Test Validated
New Genre of Small-Cell Lung Cancer Discovered
Simple Test Could Reduce Treatment of Bladder Cancer
Recurrent Rearrangements Identified in Soft Tissue Tumors
Tissue-Imaging Technology Enables Real-Time Diagnostics
Method Identifies Cancer in Early Onset Diabetics
Fine-Scale Histologic Features Estimated at Low Magnification
The Pathology channel details advances in the field of Surgical Pathology and all its subspecialties, including Cytopathology and its subspecialties.
